1. Home
  2. ROIV vs NVR Comparison

ROIV vs NVR Comparison

Compare ROIV & NVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$29.34

Market Cap

20.7B

Sector

Health Care

ML Signal

HOLD

Logo NVR Inc.

NVR

NVR Inc.

HOLD

Current Price

$5,725.32

Market Cap

17.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
NVR
Founded
2014
1980
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
20.7B
17.9B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
ROIV
NVR
Price
$29.34
$5,725.32
Analyst Decision
Strong Buy
Hold
Analyst Count
9
5
Target Price
$28.94
$7,157.80
AVG Volume (30 Days)
4.4M
13.5K
Earning Date
05-28-2026
04-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
67.76
Revenue
$29,053,000.00
$10,323,959,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$744.61
$6.60
P/E Ratio
N/A
$85.60
Revenue Growth
N/A
N/A
52 Week Low
$10.58
$5,794.98
52 Week High
$30.33
$8,618.28

Technical Indicators

Market Signals
Indicator
ROIV
NVR
Relative Strength Index (RSI) 59.02 28.64
Support Level $27.00 N/A
Resistance Level $30.26 $7,735.76
Average True Range (ATR) 0.87 180.52
MACD 0.09 -51.56
Stochastic Oscillator 85.95 5.72

Price Performance

Historical Comparison
ROIV
NVR

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About NVR NVR Inc.

NVR Inc is engaged in the construction and sale of residential properties, including single-family detached homes, townhomes, and condominium buildings, all of which are built on a pre-sold basis. Additionally, the company provides related services through its mortgage banking and title services businesses. Its business segments are Homebuilding and Mortgage Banking. Its geographical segments include the Mid Atlantic, the North East, the Mid East, and the South East regions of America. The majority of the company's revenue is derived from the Homebuilding Mid Atlantic segment, which includes homebuilding operations that construct and sell single-family detached homes, townhomes and condominiums in Maryland, Virginia, West Virginia, Delaware and Washington, D.C. regions.

Share on Social Networks: